Nothing is a hundred percent. Chemgenex has been on a tear and I haven't sold. That could be a mistake if they don't get priority review.
If it doesn't get priority review then I would agree with you that the data isn't as good as I think it is. I am almost positive that they will get it. If they don't I will have to eat crow and lose a lot of money.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.